To assess the role of IL-33 in uterine leiomyoma tumor burden, serum levels were measured in women with uterine leiomyoma and leiomyoma-free controls after complete surgical exploration of the abdominopelvic cavity [102]. Here, IL33 is linked to leiomyoma.